Patients with locally advanced non-small-cell lung cancer treated with concurrent chemotherapy and proton-beam therapy may have significantly less bone marrow toxicity. Medscape Medical News
For patients with testicular cancer in complete remission, is a postchemotherapy retroperitoneal lymph node dissection needed? Dr. Howard Hochster reports on a study that answers this question. Medscape Hematology-Oncology
Immunotherapy has long been the standard of care for the treatment of metastatic RCC, but targeted therapies also play an increasingly important role. Therapeutic Advances in Medical Oncology
